These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35396598)

  • 1. Impact of COVID-19 on Healthcare Resource Utilisation Among Patients with Inflammatory Bowel Disease in the USA.
    Ungaro RC; Chou B; Mo J; Ursos L; Twardowski R; Candela N; Colombel JF
    J Crohns Colitis; 2022 Sep; 16(9):1405-1414. PubMed ID: 35396598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding telehealth options during the COVID pandemic eliminated racial and age disparities in electronic communication by inflammatory bowel disease patients.
    Hayrapetian L; Zepp M; Rao S; Hennessey M; Houle M; Atienza M; Belfaqeeh OA; Dharia I; Khan A; Borum ML
    J Natl Med Assoc; 2021 Aug; 113(4):474-477. PubMed ID: 33941370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the Impact of COVID-19 on IBD Outcomes Among Vulnerable Patient Populations in a Large Metropolitan Center.
    Odufalu FD; Sewell JL; Rudrapatna V; Somsouk M; Mahadevan U
    Inflamm Bowel Dis; 2024 Jan; 30(1):29-37. PubMed ID: 36943305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telehealth model of care for outpatient inflammatory bowel disease care in the setting of the COVID-19 pandemic.
    Shah R; Wright E; Tambakis G; Holmes J; Thompson A; Connell W; Lust M; Niewiadomski O; Kamm M; Basnayake C; Ding J
    Intern Med J; 2021 Jul; 51(7):1038-1042. PubMed ID: 34278693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivering inflammatory bowel disease care across distance.
    Lim MH; McMahon A; Radford-Smith G
    Intern Med J; 2022 Mar; 52(3):411-417. PubMed ID: 32975818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological Therapy for Inflammatory Bowel Disease During the COVID-19 Pandemic: Experiences From a Tertiary IBD Service.
    Markovic S; Ivanovski TK; Zogovic B; Cvetkovic M; Svorcan P
    Inflamm Bowel Dis; 2020 Nov; 26(12):e152. PubMed ID: 33043961
    [No Abstract]   [Full Text] [Related]  

  • 7. A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease.
    Sack C; Phan VA; Grafton R; Holtmann G; van Langenberg DR; Brett K; Clark M; Andrews JM
    J Crohns Colitis; 2012 Apr; 6(3):302-10. PubMed ID: 22405166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory Bowel Disease Management in a Romanian Tertiary Gastroenterology Center: Challenges of the COVID-19 Pandemic.
    Vadan R; Iacob R; Costache R; Stroie T; Saizu IA; Iacob S; Gheorghe L; Diculescu M; Gheorghe C
    J Gastrointestin Liver Dis; 2020 Dec; 29(4):549-553. PubMed ID: 33331349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding attitudes, concerns, and health behaviors of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemic.
    Goodsall TM; Han S; Bryant RV
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1550-1555. PubMed ID: 33063927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of COVID-19 pandemic on IBD surgery: a single center experience.
    Pastena D; Giambusso M; Potenza AE; Caprino P; Sacchetti F; Armuzzi A; Sofo L
    Eur Rev Med Pharmacol Sci; 2022 Oct; 26(19):7313-7316. PubMed ID: 36263544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care.
    Saibeni S; Scucchi L; Dragoni G; Bezzio C; Miranda A; Ribaldone DG; Bertani A; Bossa F; Allocca M; Buda A; Mocci G; Soriano A; Mazzuoli S; Bertani L; Baccini F; Loddo E; Privitera AC; Sartini A; Viscido A; Grossi L; Casini V; Gerardi V; Ascolani M; Ruscio MD; Casella G; Savarino E; Stradella D; Pumpo R; Cortelezzi CC; Daperno M; Ciardo V; Nardone OM; Caprioli F; Vitale G; Cappello M; Comberlato M; Alvisi P; Festa S; Campigotto M; Bodini G; Balestrieri P; Viola A; Pugliese D; Armuzzi A; Fantini MC; Fiorino G;
    United European Gastroenterol J; 2020 Dec; 8(10):1228-1235. PubMed ID: 33070758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telemonitoring for patients with inflammatory bowel disease amid the COVID-19 pandemic-A cost-effectiveness analysis.
    Yao J; Fekadu G; Jiang X; You JHS
    PLoS One; 2022; 17(4):e0266464. PubMed ID: 35390064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the Coronavirus Disease Pandemic on Health-Related Quality of Life of Patients with Inflammatory Bowel Disease.
    Paulides E; Pasma A; Erler NS; van Eijk RLA; de Vries AC; van der Woude CJ
    Dig Dis Sci; 2022 Jul; 67(7):2849-2856. PubMed ID: 34181168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey.
    Martin Arranz E; Suarez Ferrer C; García Ramírez L; Rueda García JL; Sánchez-Azofra M; Poza Cordón J; Noci J; Zabana Y; Barreiro-de Acosta M; Martín-Arranz MD
    Inflamm Bowel Dis; 2020 Jul; 26(8):1149-1154. PubMed ID: 32495826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the repercussions of COVID-19 pandemic on symptoms, disease management, and emotional well-being in patients with inflammatory bowel disease: a multi-site survey study.
    El-Dallal M; Saroufim A; Systrom H; Ballou S; Farhoud A; Pasam RT; Gadupudi SS; Osman K; Chaudrey K; Cheifetz A; Feuerstein JD
    Scand J Gastroenterol; 2022 Apr; 57(4):406-414. PubMed ID: 34894999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of biologics in inflammatory bowel disease patients with COVID-19.
    Weissman S; Aziz M; Smith WL; Elias S; Swaminath A; Feuerstein JD
    Int J Colorectal Dis; 2021 Sep; 36(9):2051-2055. PubMed ID: 34131784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.
    Kuenzig ME; Lee L; El-Matary W; Weizman AV; Benchimol EI; Kaplan GG; Nguyen GC; Bernstein CN; Bitton A; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S34-S41. PubMed ID: 31294383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Healthcare Utilization by Patients With Inflammatory Bowel Disease Covered by Medicaid at a Tertiary Care Center.
    Axelrad JE; Sharma R; Laszkowska M; Packey C; Rosenberg R; Lebwohl B
    Inflamm Bowel Dis; 2019 Sep; 25(10):1711-1717. PubMed ID: 30989212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the COVID-19 Pandemic on Health Care Utilization in a Large Integrated Health Care System: Retrospective Cohort Study.
    Xu S; Glenn S; Sy L; Qian L; Hong V; Ryan DS; Jacobsen S
    J Med Internet Res; 2021 Apr; 23(4):e26558. PubMed ID: 33882020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.